Literature DB >> 24397826

Dress syndrome induced by levetiracetam.

K Eleni1.   

Abstract

BACKGROUND: The tremendous increase in the use of drugs has considerably increased their side effects.
OBJECTIVES: The aim of this work is to demonstrate Dress syndrome induced by levetiracetam an anti-epileptic drug.
METHODS: We describe a skin eruption observed in an-hospitalized in an intensive care unit patient who received levetiracetam.
RESULTS: According to morphology of the rash and the laboratory findings the rash fulfills the criteria for Dress syndrome.
CONCLUSION: Levetiracetam may induce Dress syndrome.
© 2014 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24397826     DOI: 10.1111/jdv.12346

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  4 in total

1.  Levetiracetam Induced Drug Reaction with Eosinophilia and Systemic Symptom Syndrome.

Authors:  Waseem Raja Dar; Najeebullah Sofi; Muzamil Latief; Imtiyaz Ahmad Dar; Basharat Ahmad Kasana
Journal:  Indian J Dermatol       Date:  2016 Mar-Apr       Impact factor: 1.494

2.  Spectrum of Cutaneous Adverse Reactions to Levetiracetam and Human Leukocyte Antigen Typing in North-Indian Patients.

Authors:  Bhargavi Ramanujam; Kavish Ihtisham; Gurvinder Kaur; Shivani Srivastava; Narinder Kumar Mehra; Neena Khanna; Mahip Singh; Manjari Tripathi
Journal:  J Epilepsy Res       Date:  2016-12-31

3.  Hallucination: A rare complication of levetiracetam theraphy.

Authors:  Seher Erdogan; Mehmet Bosnak
Journal:  North Clin Istanb       Date:  2017-10-18

4.  Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles.

Authors:  Zhan-Miao Yi; Cheng Wen; Ting Cai; Lu Xu; Xu-Li Zhong; Si-Yan Zhan; Suo-Di Zhai
Journal:  Neuropsychiatr Dis Treat       Date:  2018-12-17       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.